Alex

New Chinese Restrictions on Supply of Natural Graphite Will Negatively Impact Batteries Used in EV Market

Westwater Resources Offers Domestic Alternatives CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (NYSE: American: WWR), an energy technology and battery-grade natural graphite…

3 years ago

Nanban Ventures Sends Letter Highlighting Steps Being Taken to Protect Investors

DALLAS--(BUSINESS WIRE)--Nanban Ventures LLC (“Nanban Ventures”), a Dallas-based venture capital firm investing in startups and other private companies that are…

3 years ago

Avistone Announces Phase II Results for Vebreltinib, a c-Met Tyrosine Kinase Inhibitor (TKI) at the European Society for Clinical Oncology (ESMO) Congress

BEIJING--(BUSINESS WIRE)--Avistone Biotechnology Co., Ltd. (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology therapeutics, announced preliminary…

3 years ago

ENHERTU® Demonstrated Clinically Meaningful Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial

Daiichi Sankyo and AstraZeneca’s ENHERTU showed a median progression-free survival of 6.9 months and median overall survival of 13.4 months…

3 years ago

Datopotamab Deruxtecan Improved Progression-Free Survival Versus Chemotherapy in Patients with Previously Treated Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial

Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan reduced the risk of disease progression or death by 25% in overall population and…

3 years ago

Datopotamab Deruxtecan Significantly Extended Progression-Free Survival Versus Chemotherapy in Patients with HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial

Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan reduced the risk of disease progression or death by 37%, providing a 2-month median…

3 years ago

athenahealth’s Annual ‘September is for Service’ Program Supports 50 Nonprofit Organizations Worldwide

Month-long campaign delivers more than $100,000 to nonprofit partners, with record employee participation BOSTON--(BUSINESS WIRE)--athenahealth, Inc., a leading provider of…

3 years ago

Edgecore Networks Introduces its New Wi-Fi 6 & Wi-Fi 6E Access Points for Mastering Every Terrain

Embracing Resilient Wi-Fi 6 & Wi-Fi 6E Connectivity with Edgecore Wi-Fi HSINCHU, Taiwan--(BUSINESS WIRE)--Edgecore Networks, a leading provider of traditional…

3 years ago

Expensify Unveils Personal Payments and Bill Splitting for Everyone

The spend management app now lets anyone send and receive money, split bills, and chat all in one place. LAS…

3 years ago

Long-Term Commitment to Sustainable Development and Continued Build-Out of AMTD IDEA and AMTD Digital

PARIS & NEW YORK & SINGAPORE--(BUSINESS WIRE)--AMTD IDEA Group (NYSE: AMTD; SGX: HKB) (“AMTD IDEA”), and AMTD Digital Inc. (NYSE:…

3 years ago

Global Roofing Underlayment Market Projected to Reach US$8.9 Billion by 2028, Driven by Rising Demand for Durable and Energy-Efficient Solutions – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Roofing Underlayment Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2023-2028" report has been added to…

3 years ago

One Equity Partners Agrees to Sell Walki to Japan’s Oji Group

Firm Supported Walki’s Sustainability Initiatives Over Five Years of Ownership NEW YORK & FRANKFURT, Germany--(BUSINESS WIRE)--#exit--One Equity Partners (“OEP”) today…

3 years ago

Lomiko Metals Reflects on China’s Move to Limit Graphite Exports and Announces Corporate Update, and Annual and Special Meeting of Shareholders on December 20th, 2023

MONTREAL--(BUSINESS WIRE)--Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko Metals” or the “Company”) reflects on the news regarding China's announcements to limit…

3 years ago

Canva Introduces Student-Safe AI Products, Customizable Lessons for Teachers, and Over 5,000 Free Classroom Resources to 50 Million Students and Teachers

Releases AI in Education Report, revealing 93% don’t know where to start with AI Unveils the world’s first range of…

3 years ago

ImmuneOncia Announces Phase 1 Results of CD47 Antibody at ESMO 2023

SEOUL, South Korea--(BUSINESS WIRE)--ImmuneOncia (CEO Heung Tae Kim) announced the results of its Phase 1a solid tumour clinical trial (IMC-002-K102…

3 years ago